Difference between revisions of "Plasmacytoid urothelial carcinoma"

Plasmacytoid urothelial carcinoma (view source)

594 bytes added , 17:35, 17 August 2016

48,589

edits

@@ Line 78: / Line 78: @@
 *HER2 +ve/-ve.
 **In a series of 6 cases: 4 cases were 3+, one case was 2+, one case negative.<ref name=pmid27034533>{{Cite journal  | last1 = Kim | first1 = B. | last2 = Kim | first2 = G. | last3 = Song | first3 = B. | last4 = Lee | first4 = C. | last5 = Park | first5 = JH. | last6 = Moon | first6 = KC. | title = HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder. | journal = Dis Markers | volume = 2016 | issue =  | pages = 8463731 | month =  | year = 2016 | doi = 10.1155/2016/8463731 | PMID = 27034533 }}</ref>
+**HER2 status ''not'' a predictor of survival in UCC patients.<ref name=pmid25720673>{{Cite journal  | last1 = Bellmunt | first1 = J. | last2 = Werner | first2 = L. | last3 = Bamias | first3 = A. | last4 = Fay | first4 = AP. | last5 = Park | first5 = RS. | last6 = Riester | first6 = M. | last7 = Selvarajah | first7 = S. | last8 = Barletta | first8 = JA. | last9 = Berman | first9 = DM. | title = HER2 as a target in invasive urothelial carcinoma. | journal = Cancer Med | volume = 4 | issue = 6 | pages = 844-52 | month = Jun | year = 2015 | doi = 10.1002/cam4.432 | PMID = 25720673 }}</ref>
 ==Molecular==